03 May 2007 ThromboGenics Announces Progress With its Pre-Clinical and Clinical Programs
03 May 2007 Y's Therapeutics Initiates Phase II Trial With YSPSL in Liver Transplant Patients for Prevention of Ischemic Reperfusion (I/R) Injury
02 May 2007 Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
02 May 2007 Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology
01 May 2007 Dr. Reddy's launches Reditux(TM) Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma
01 May 2007 Final Vectibix(TM) Positive Pivotal Phase 3 Trial Results In Metastatic Colorectal Cancer Patients Published
28 Apr 2007 Abbott's HUMIRA(R) (adalimumab) Receives Positive Opinion from European Medicines Agency for the Treatment of Crohn's Disease
28 Apr 2007 CHMP Adopts Positive Opinion For Alexion's Soliris(TM) In Europe
27 Apr 2007 PDL BioPharma Advances Nuvion(R) Into Second Pivotal Study in Intravenous Steroid-Refractory Ulcerative Colitis
27 Apr 2007 Royalty Pharma and InNexus Biotechnology Announce Agreement Regarding the Purchase of Royalty Rights Based on DXL(TM) Antibody Products
25 Apr 2007 Y's Therapeutics Completes Enrollment of Phase II Trial in the U.S. With YSPSL for Prevention of Delayed Graft Function in Renal Transplantation
24 Apr 2007 Micromet Achieves Milestone in BiTE(R) Research Collaboration with MedImmune
24 Apr 2007 KaloBios Licenses Humaneering(TM) Technology to Major Pharmaceutical Company
20 Apr 2007 MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE(R) Molecule
19 Apr 2007 Anti-Cancer Agent Avastin(R), Approved in Japan
19 Apr 2007 Viventia Biotech generates novel human anti-cancer antibody, VB1-050, and identifies its novel target
18 Apr 2007 Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in Cancer Animal Models
18 Apr 2007 Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Both Hormone-Dependent and Hormone-Independent Prostate Cancer by Up to 94 Percent in Preclinical Studies
18 Apr 2007 Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
17 Apr 2007 YM BioSciences' Partner Daiichi Sankyo Receives Clearance for Initial Clinical Trial in Japan
17 Apr 2007 Randomized Phase III Trial Showed ERBITUX Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients
17 Apr 2007 Data Presented at AACR Meeting Shows Peregrine's Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
13 Apr 2007 Genmab Initiates HuMax-EGFr Combination Study in Non Small Cell Lung Cancer
13 Apr 2007 XOMA Announces Clinical Trial Plans for XOMA 052 in Type 2 Diabetes
07 Apr 2007 FDA approves Cangene's HepaGam B(TM) for a second indication; for use in hepatitis B-positive liver transplant recipients

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up